69
Participants
Start Date
May 10, 2017
Primary Completion Date
January 31, 2019
Study Completion Date
April 30, 2019
Evofosfamide
Evofosfamide given on day one and in combination with Ipilimumab on day 8 of the first two cycles, Ipilimumab given alone on day 8 of last two cycles for a total of four 21 day dosing cycles.
Ipilimumab
Evofosfamide given on day one and in combination with Ipilimumab on day 8 of the first two cycles, Ipilimumab given alone on day 8 of last two cycles for a total of four 21 day dosing cycles.
RECRUITING
MD Anderson Cancer Center, Houston
Lead Sponsor
M.D. Anderson Cancer Center
OTHER
Threshold Pharmaceuticals
INDUSTRY